Latrogenic and zoonotic Creutzfeldt-jakob disease: The Australian perspective

Medical Journal of Australia

Volumn 164, Issue 10, 1996, Pages 598-602

  Collins, Steven ^a   Masters, Colin L ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GONADOTROPIN; GROWTH HORMONE; HYPOPHYSIS HORMONE;

AUSTRALIA; BRAIN GRAFT; BRAIN SPONGIOSIS; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; DRUG CONTAMINATION; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; INFECTION; INFERTILITY; INHERITANCE; REVIEW; SHORT STATURE; ANIMAL; DURA MATER; GENETICS; IATROGENIC DISEASE; POSTOPERATIVE COMPLICATION; TRANSPLANTATION; ZOONOSIS;

ANIMALS; CREUTZFELDT-JAKOB SYNDROME; DURA MATER; HUMANS; IATROGENIC DISEASE; PITUITARY HORMONES; POSTOPERATIVE COMPLICATIONS; ZOONOSES;

EID: 0029664899     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1996.tb122202.x     Document Type: Review

References (35)

1. Prusiner SB, Hsiao KK. Human prion diseases. Ann Neural 1994; 35: 385-395.
2. Collinge J, Rossor M. A new variant of prion disease [commentary]. Lancet 1996; 347: 916-917.
3. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancer 1996; 347: 921-925.
4. Palmer MS, Collinge J. Human prion diseases. Cuir Opin Neurol Neurosurg 1992; 5: 895-901.
5. Kocisko DA, Come JH, Priola SA, et al. Cell-free formation of protease-resistant prion protein. Nature 1994; 370: 471-474.
6. Telling GC, Scott M, Mastrianni J, et al. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 1995; 83: 79-90.
7. Owen F, Poulter M, Lofthouse R, et al. Insertion in prion protein gene in familial Creutzfeldt-Jakob disease. Lancet 1989; 1: 51-52.
8. Brown P The phenotypic expression of different mutations in transmissible human spongiform encephalopathy. Rev Neurol 1992; 148: 317-327.
9. Medori R, Tritschler H-J, LeBlanc A, et al. Fatal familial insomnia, a prion disease with a mutation at codon 17B of the prion protein gene. N Engl J Med 1992; 326: 444-449.
10. Kitamoto T, lizuka R, Tateishi J. An amber mutation of prion protein in Gerstmann-Sträussler syndrome with mutant PrP plaques. Biochem Biophys Res Commun 1993; 192: 525-531.
11. Kitamoto T, Amano N, Terao Y, et al. A new inherited prion disease (PrP-P105L mutation) showing spastic paraparesis. Ann Neurol 1993; 34: 808-813.
12. Brown R Cathala F Castaigne R Gajdusek DC. Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol 1986; 20: 597-602.
13. Brown R Preece MA, Will RG. "Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet 1992; 340: 24-27.
14. Duffy P, Wolf J, Collins G, et al. Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med 1974; 290: 692-693.
15. Bernoulli C, Siegfried J, Baumgartner G, et al. Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet 1977; 1: 478-479.
16. Will RG, Matthews WB. Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 1982; 45: 235-238.
17. Thadani V, Penar PL, Partington J, et al. Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. J Neurosurg 1988; 69: 766-769.
18. Simpson DA, Masters CL, Ohlrich G, et al. Iatrogenic Creutzfeld-Jakob disease and its neurosurgical implications. J Clin Neurosei 1996; 3:118-123.
19. Gibbs CJ Jr, Joy A, Heffner R, et al. Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med 1985; 313: 734-738.
20. Cochius JI, Mack K, Burns RJ, et al. Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin. Aust N Z J Med 1990; 20: 592-593.
21. Brown P An epidemiologic critique of Creutzfedt-Jakob disease. Epidemiol Rev 1980; 2: 113-135.
22. Ridley RM, Baker HF. Occupational risks of Creutzfeldt-Jakob disease. Lancet 1993; 341: 641-642
23. Berger J, David NJ. Creutzfeldt-Jakob disease in a physician: a review of the disorder in health care workers. Neurology 1993; 43: 205-206.
24. Brown R Gibbs CJ Jr, Rodgers-Johnson R et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994; 35: 513-529.
25. Cochius JI, Hyman N, Esiri MM. Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin: a second case. J Neurol Neurosurg Psychiatry 1992; 55: 1094-1095.
26. Masters CL, Richardson EP Jr Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease): the nature and progression of spongiform change. Brain 1978; 101: 333-344.
27. Collinge J, Palmer MS, Dryden AJ. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 1991; 337: 1441-1442.
28. Tateishi T Transmission of Creutzfeldt-Jakob disease from human blood and urine into mice [letter]. Lancer 1985; 2:1074.
29. Tamai Y, Kojima H, Kitajima R, et al. Demonstration of the transmissible agent in tissue from a pregnant woman with Creutzteldt-Jakob disease. N Engl J Med 1992; 327: 649.
30. Manuelidis E, Kim JH, Mericangas JR, Manuelidis L. Transmission to animals of Creutzfeldt-Jakob disease from human blood. Lancet 1985; 2: 896-897.
31. Manuelidis EE, Gorgacz EJ, Manuelidis L. Viremia in experimental Creutzfeldt-Jakob disease. Science 1978; 200: 1069-1071.
32. Klein RD, Dumble LJ. Transmission of Creutzfeldt-Jakob disease by blood transfusion. Lancet 1993; 341: 768.
33. Brown P, Gibbs CJ Jr, Amyx HL, et al. Chemical disinfection of Creutzfeldt-Jakob disease virus. N Engl J Med 1982; 306: 1279-1282.
34. Budka H, Aguzzi A, Brown R et al. Tissue handling in suspected Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 1995; 5: 319-322.
35. National Health and Medical Research Council of Australia. Creutzfeldt-Jakob disease and other human transmissible encephalopathies: guidelines on patient management and infection control. Canberra: NHMRC/AGPS, 1996: 46p.